Finasteride vs dutasteride is a common decision point in male pattern hair loss (androgenetic alopecia). Both are 5-alpha reductase inhibitors (DHT blockers), but they differ in enzyme targets, regulatory status for hair loss, how long they persist in the body, and how clinicians typically use them in real practice.
Medical note: This article is for general education and does not provide personal medical advice. These are prescription medicines and are not appropriate for everyone. If you’re not sure you have pattern hair loss, start with How Hair Loss Is Diagnosed. If you have red flags (scalp pain/burning, pus/crusting, heavy scale, open sores, or rapid worsening), start here: When to See a Doctor.
Quick navigation
- Key takeaways (fast)
- What they are (plain English)
- Finasteride vs dutasteride: key differences
- Evidence: what studies show
- Timeline: when to judge results
- Side effects & safety (sexual, mood, PSA)
- Pregnancy handling & blood donation warnings
- How to choose (practical decision framework)
- Monitoring checklist
- FAQ
- References
Key takeaways (fast)
- Finasteride (1 mg) is FDA-approved for male pattern hair loss in men only and may take 3+ months before benefit is observed.
- Dutasteride (0.5 mg) is FDA-approved for BPH, not for hair loss in the U.S. (hair-loss use is often off-label where used).
- Potency difference: dutasteride inhibits type 1 + type 2 5α-reductase, while finasteride is more selective (commonly described as type 2-focused).
- Evidence: a large 24-week randomized trial found dutasteride 0.5 mg improved hair measures more than finasteride 1 mg in men with AGA.
- Safety is real: regulators highlight mood/psychiatric warnings for finasteride, plus sexual side effects and PSA interpretation issues for both classes.
- Use the roadmap hubs: Androgenetic Alopecia Hub • Finasteride & Dutasteride Hub • Treatment Overview.
What they are (plain English)
In androgenetic alopecia, genetically sensitive follicles miniaturize under DHT signaling over time. DHT blockers reduce conversion of testosterone to DHT by inhibiting 5-alpha reductase enzymes. In real terms, this can help slow progression and, in some people, increase density when used consistently long term.
Finasteride vs dutasteride: key differences
1) Regulatory status (hair loss)
- Finasteride 1 mg: indicated for male pattern hair loss in men only (per FDA labeling).
- Dutasteride 0.5 mg: indicated for BPH (per FDA labeling). Hair-loss use is off-label in the U.S.
2) Enzyme targets & “how strong” DHT reduction can be
- Finasteride: commonly described as more selective (type II-focused).
- Dutasteride: inhibits type 1 + type 2 isoenzymes (often described as stronger overall DHT suppression).
3) Persistence in the body
Dutasteride has long persistence; FDA labeling notes serum dutasteride can remain detectable for months after stopping, and it includes a blood donation restriction after the last dose.
Evidence: what studies show
One of the most-cited comparisons is a large randomized trial (week 24) where dutasteride 0.5 mg improved hair count/width measures more than finasteride 1 mg in men with androgenetic alopecia.
Practical interpretation: this supports why some clinicians discuss dutasteride when response to finasteride is not strong enough or progression is more aggressive — but it doesn’t eliminate the need for a risk discussion.
Timeline: when to judge results
- Finasteride label anchor: daily use for 3 months or more may be needed before benefit is observed.
- Real-world expectation: meaningful change is often judged on a months-long horizon (photos every 4 weeks help more than day-to-day checking).
- Stopping effect: discontinuation typically leads to gradual loss of gains over time.
Side effects & safety (sexual, mood, PSA)
Sexual side effects
FDA labeling for finasteride lists sexual adverse reactions (e.g., decreased libido, erectile dysfunction, ejaculation disorder) in a minority of users. Dutasteride labeling similarly lists sexual adverse reactions among common events in its approved-use trials.
Mood / psychiatric warnings
Regulators in Europe and the UK have issued risk communications about psychiatric side effects (including suicidal thoughts for finasteride) and have recommended patient-facing risk minimization information.
PSA notes (important)
Both drug labels emphasize that 5-alpha reductase inhibitors can lower PSA, which can affect interpretation. Always tell your clinician you are taking (or have taken) a DHT blocker before PSA testing.
Pregnancy handling & blood donation warnings
- Finasteride: women who are pregnant or may become pregnant should not handle crushed/broken tablets.
- Dutasteride: women who are pregnant or may become pregnant should not handle capsules (especially leaking capsules), as it can be absorbed through the skin.
- Dutasteride blood donation: FDA labeling advises men not to donate blood until 6 months after the last dose.
How to choose (practical decision framework)
- Confirm diagnosis first: if it’s not AGA, DHT blockers won’t fix the root problem. Use How Hair Loss Is Diagnosed.
- Start with a clear plan: most men start with finasteride (on-label for hair loss) + minoxidil if appropriate.
- Reassess at a realistic time point: track photos monthly; don’t judge at 2 weeks.
- Consider escalation only with clinician guidance: dutasteride is typically an “escalation” discussion when response is insufficient or progression is fast, balancing potency vs long persistence and label warnings.
Monitoring checklist
- Monthly photos (same lighting, same angle).
- Track mood changes; seek medical advice promptly if depression/suicidal thoughts occur.
- Track sexual side effects objectively (don’t ignore them; don’t panic either).
- PSA: tell clinicians before testing.
- Pregnancy safety: store securely; avoid exposure of broken tablets/leaking capsules to pregnant women.
FAQ
Is dutasteride “better” than finasteride?
Some trials show stronger average improvement with dutasteride 0.5 mg at 24 weeks, but “better” depends on diagnosis, safety tolerance, and clinician supervision.
Can I switch back and forth?
Do not self-switch without clinician guidance. Dutasteride persists longer, and both drugs have safety and monitoring implications.
Should women use these for hair loss?
Finasteride 1 mg is not indicated for women per FDA labeling, and both drugs carry pregnancy exposure warnings. Women should only discuss off-label hormonal approaches with a qualified clinician.
References (trusted medical sources)
- FDA label: Propecia (finasteride 1 mg) — indication for men only, 3+ month timeline, PSA and pregnancy handling warnings
- FDA label: Avodart (dutasteride) — pregnancy handling warning, PSA, blood donation restriction
- Harcha et al. (2014): randomized controlled trial comparing dutasteride vs finasteride at week 24
- EMA: measures to minimise risk of suicidal thoughts (finasteride/dutasteride)
- UK MHRA: finasteride reminder (psychiatric + sexual side effects)
Last updated: February 28, 2026.
